4//SEC Filing
Matushansky Igor 4
Accession 0001104659-22-003430
CIK 0001760542other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 10:07 AM ET
Size
19.6 KB
Accession
0001104659-22-003430
Insider Transaction Report
Form 4
Matushansky Igor
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-12-21−11,366→ 2,842 totalExercise: $0.10Exp: 2026-12-31→ Common Stock (11,366 underlying) - Sale
Common Stock
2021-12-21$2.49/sh−5,304$13,207→ 80,178 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-21−3,408→ 4,261 totalExercise: $0.10Exp: 2026-12-31→ Common Stock (3,408 underlying) - Exercise/Conversion
Common Stock
2021-12-21$0.10/sh+3,408$341→ 87,512 total - Sale
Common Stock
2021-12-21$2.49/sh−2,205$5,490→ 85,307 total - Exercise/Conversion
Common Stock
2021-12-21$0.10/sh+8,079$808→ 85,482 total - Sale
Common Stock
2021-12-21$2.49/sh−7,440$18,526→ 84,104 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-21−8,079→ 0 totalExercise: $0.10Exp: 2026-12-31→ Common Stock (8,079 underlying) - Exercise/Conversion
Common Stock
2021-12-21$0.10/sh+11,366$1,137→ 91,544 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021.
- [F2]25% of this option vested and became exercisable on March 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 129,212 shares and the Reporting Person has exercised his option to purchase 129,212 shares.
- [F3]25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 45,466 shares and the Reporting Person has exercised his option to purchase 42,624 shares.
- [F4]25% of this option vested and became exercisable on January 1, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 13,634 shares and the Reporting Person has exercised his option to purchase 9,373 shares.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001768208
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 10:07 AM ET
- Size
- 19.6 KB